MGMT-Methylated Glioblastoma
generalA glioblastoma characterized by the absence of DNA methylation in the promoter region of the MGMT gene. It is associated with a poor outcome.
23
Centers
1
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Recurrent MGMT-Methylated Glioblastoma | 23 |
Top Centers for MGMT-Methylated Glioblastoma(23)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →